e16554Background: The use of everolimus (E) monotherapy to treat RCC has diminished due to the approvals of new agents. We hypothesized that gene expression associated with benefit may provide the… Click to show full abstract
e16554Background: The use of everolimus (E) monotherapy to treat RCC has diminished due to the approvals of new agents. We hypothesized that gene expression associated with benefit may provide the ...
               
Click one of the above tabs to view related content.